Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lung Neoplasms × Irinotecan × Clear all

Phase

Status

Completed 28 Terminated 5 Active not recruiting 4 Unknown 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 12 Rectal Neoplasms 7 Colonic Neoplasms 5 Pancreatic Neoplasms 3 Stomach Neoplasms 2 Glioblastoma 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Solid Tumor Malignancy 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Prostatic Neoplasms 1 Pediatric Solid Tumors 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Gliosarcoma 1 Gallbladder Neoplasms 1 Colorectal Adenocarcinoma Metastatic to the Liver 1 Breast Neoplasms, Male 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Carboplatin 18 Radiotherapy 10 Cisplatin 10 Pemetrexed 8 Paclitaxel 8 durvalumab 6 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 Radiosurgery 5 Etoposide 5 Surveys and Questionnaires 4 Radiation 4 Nivolumab 4 Erlotinib Hydrochloride 4 Docetaxel 4 pembrolizumab 3 atezolizumab 3 Taxes 3 Standard of Care 3 Specimen Handling 3 Platinum 3 Cetuximab 3 Bronchoscopy 3 Biopsy 3 Bevacizumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 sapanisertib 2 etoposide phosphate 2 capmatinib 2 Vinorelbine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01654081 2014-05-30

A Protocol of Irinotecan for Carcinoma of the Lung

University of Kentucky

Phase 2 Withdrawn

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡